Searcharxiv⌕ Search
Home/Archive/arXiv

arXiv · 2606.22318

PROMPT: A Pre-registered Randomized Protocol for Component-Level Evaluation of Clinical AI Prompts

Bin Hu·Avneek Sandhu·Shahryar Wasif
View original source ↗Read source document ↗Export metadata ↓

Abstract

BACKGROUND:Prompt engineering shapes medical AI outcomes, but prompt components are rarely tested as clinical interventions. We developed PROMPT (Pre-registered Randomized Outcome Measurement for Prompt Testing), a protocol using pre-specification, randomization, matched controls, dismantling, and decision rules.METHODS:Two pre-registered demonstrations used Claude Sonnet 4.6. Exp 1 used a synthetic tumbling-E orientation task: 630-trial main study, 480-trial dismantling study, and 1,050-trial 2x2 factorial extension. Exp 2 used the same arms on 16 label-masked CBIS-DDSM mammographic crops in four orientations: 256 confirmatory trials and a 64-trial Arm E extension. Matched controls removed the active component while preserving framing, structure, and output format.RESULTS:PROMPT identified beneficial, inactive, harmful, and task-dependent effects. In Exp 1, the full prompt achieved 98.6% orientation accuracy; removing the decoding rule reduced accuracy to 50.1% (difference, +48.5 pp; 95% CI, +43.2 to +53.7; P<0.001). A rule-only arm matched the full prompt (maximum difference, 2.3 pp), identifying the decoding rule as the sole measurable active component. A prohibited-reasoning block assumed to improve safety was inactive, an effect missed by whole-prompt comparison. Scaffolding without the task-specific rule underperformed the vehicle prompt, showing prompt structure alone was harmful. Exp 1 revealed a canonical-RIGHT error phenotype in no-rule arms, consistent with a RIGHT-orientation prior. In Exp 2, the phenotype recurred on mammographic images, but the rule's benefit was attenuated and did not meet the threshold (+14.1 pp; bootstrap 95% CI, -3.1 to +29.7; post-hoc mixed-model 95% CI, +3.5 to +24.6).CONCLUSION:PROMPT revealed component effects missed by whole-prompt evaluations, identifying safety vulnerabilities and performance failures before clinical AI deployment.

Explore related subjects

q-bio.OT

Keep this discovery

BibTeXRIS

Bin Hu, Avneek Sandhu, Shahryar Wasif. 2026-06-21. PROMPT: A Pre-registered Randomized Protocol for Component-Level Evaluation of Clinical AI Prompts. https://arxiv.org/abs/2606.22318

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT↗
arXiv2026

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT↗
arXiv2026

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT↗